中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
34期
21-22
,共2页
邹乐乐%关红梅%杨莹%陈宛丽
鄒樂樂%關紅梅%楊瑩%陳宛麗
추악악%관홍매%양형%진완려
奈达铂%食管癌%化疗%老年
奈達鉑%食管癌%化療%老年
내체박%식관암%화료%노년
Nedaplatin%Esophageal cancer%Chemotherapy%The elderly
目的:对比奈达铂(NDP)联合氟尿嘧啶(5-FU)与顺铂(DDP)联合氟尿嘧啶治疗老年晚期食管癌的效果和不良反应。方法:收治老年晚期食管癌患者46例,随机分为NDP+5-FU治疗组(A组,24例)和DDP+5-FU对照组(B组,22例),比较两组患者的疗效和不良反应。结果:A组总有效率27.53%,B组总有效率22.73%(P<0.05)。A组主要不良反应为骨髓抑制,B组主要不良反应为消化道反应。结论:奈达铂治疗老年晚期食管癌患者的效果显著,不良反应小。
目的:對比奈達鉑(NDP)聯閤氟尿嘧啶(5-FU)與順鉑(DDP)聯閤氟尿嘧啶治療老年晚期食管癌的效果和不良反應。方法:收治老年晚期食管癌患者46例,隨機分為NDP+5-FU治療組(A組,24例)和DDP+5-FU對照組(B組,22例),比較兩組患者的療效和不良反應。結果:A組總有效率27.53%,B組總有效率22.73%(P<0.05)。A組主要不良反應為骨髓抑製,B組主要不良反應為消化道反應。結論:奈達鉑治療老年晚期食管癌患者的效果顯著,不良反應小。
목적:대비내체박(NDP)연합불뇨밀정(5-FU)여순박(DDP)연합불뇨밀정치료노년만기식관암적효과화불량반응。방법:수치노년만기식관암환자46례,수궤분위NDP+5-FU치료조(A조,24례)화DDP+5-FU대조조(B조,22례),비교량조환자적료효화불량반응。결과:A조총유효솔27.53%,B조총유효솔22.73%(P<0.05)。A조주요불량반응위골수억제,B조주요불량반응위소화도반응。결론:내체박치료노년만기식관암환자적효과현저,불량반응소。
Objective:To explore the curative effect and adverse reactions of nedaplatin combined with 5-fluorouracil and cisplatin combined with 5-fluorouracil in the treatment of elderly patients with advanced esophageal cancer.Methods:46 elderly patients with advanced esophageal cancer were selected,they were randomly divided into NDP+5-FU treatment group(A group,24 cases) and DDP+5-FU control group(B group,22 cases),we compared the efficacy and adverse reactions of the two groups.Results:The total effective rate in the A group was 27.53%,and the total effective rate in the B group was 22.73%(P<0.05).In the A group, the main adverse reactions were bone marrow suppression,in the B group,the main adverse reactions were gastrointestinal reactions.Conclusion:Effect of nedaplatin in the treatment of elderly patients with advanced esophageal carcinoma was significant, adverse reaction was small.